1. Home
  2. SMJF vs ACET Comparison

SMJF vs ACET Comparison

Compare SMJF & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$5.24

Market Cap

88.7M

Sector

N/A

ML Signal

N/A

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.81

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMJF
ACET
Founded
1988
1947
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
77.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SMJF
ACET
Price
$5.24
$7.81
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$48.33
AVG Volume (30 Days)
605.1K
103.7K
Earning Date
09-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$68.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.46
52 Week High
$5.70
$9.47

Technical Indicators

Market Signals
Indicator
SMJF
ACET
Relative Strength Index (RSI) 79.08 46.66
Support Level $4.50 $7.36
Resistance Level $5.64 $8.68
Average True Range (ATR) 0.39 0.60
MACD 0.10 -0.02
Stochastic Oscillator 82.21 30.63

Price Performance

Historical Comparison
SMJF
ACET

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: